ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral Vector Manufacturing.
We are pleased to announce the expansion of our GMP product range, with the introduction of M-SAN HQ GMP, a new GMP grade nuclease specifically designed for viral vector manufacturing.
ArcticZymes Technologies releases its first ESG report
Tromsø, Norway, 30st December 2022 – ArcticZymes Technologies ASA (OSE: AZT) releases its first comprehensive ESG report ArcticZymes Technologies has today released its first comprehnesive Environment, Social and Governane (ESG) report based on data for the year 2021. The report is prepared in accordance with the framework established by the Global Reporting Initiative (GRI) and the Sustainability Accounting Standards Board
ArcticZymes Technologies launches SAN HQ 2.0 ELISA Kit
ArcticZymes Technologies is pleased to announce the launch of our newest product, the SAN HQ 2.0 ELISA kit. This classic sandwich ELISA is designed for the detection and quantification of SAN HQ 2.0 enzyme in samples taken from the manufacturing stages of a complex biomanufacturing process such as the production of viral vectors. The SAN HQ 2.0 ELISA Kit is